The oncogenic activity of osteopontin has been linked to its ability to promote cancer cell proliferation, survival and invasiveness, as well as tumor angiogenesis, and an immunosuppressive tumor microenvironment [49, 50, 56, 66, 69]. This evidence concerns the gene SPP1 and neoplasm.